Clinical trial
Vaccination With Autologous Breast Cancer Cells Engineered to Secrete…
NCT00317603 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00317603 |
|---|---|
| Title | Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer Patients |
| Official title | A Phase I Trial of Vaccination With Autologous, Lethally Irradiated Breast Cancer Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Colony Stimulating Factor in Metastatic Breast Cancer Patients |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological |
| Interventions | Autologous, Lethally Irradiated Breast Cancer Cells |
| Enrollment | 15 |
| Start date | Jan 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | Jun 1, 2021 |
| First posted | Apr 25, 2006 |
| Last update posted | Apr 1, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: